物質使用障礙症個案之矩陣治療模式：系統性文獻回顧

The Matrix Model for Patients with Substance Use Disorder: A Systematic Review

10.30074/FJMH.202206_35(2).0002

李俊宏(Chun-Hung Lee)；陳薇(Wei Chen)；郭宇恆(Yu-Heng Kuo)；歐陽文貞(Wen-Chen Ouyang)

認知行為心理治療 ； 物質使用障礙症 ； 成癮 ； 矩陣治療模式 ； cognitive behavioral psychotherapy ； substance use disorder ； addiction ； Matrix Model

中華心理衛生學刊

35卷2期（2022 / 06 / 01）

117 - 143

繁體中文

研究目的：矩陣治療模式是一種結構化的密集治療方案，主要針對古柯鹼或甲基安非他命使用障礙症的患者，該治療模式結合了多種心理治療方法，已被廣泛運用於物質使用障礙症的治療當中。本研究有三個主要目的：第一，藉由回顧矩陣治療模式的療效研究，探究其發展脈絡及理論架構，歸納其治療性因素及限制；第二，回顧不同文化背景下應用矩陣治療模式的成效，歸結出可能影響治療效果的潛在因素；第三，考量臺灣的社會文化，提出矩陣治療模式應用在國內藥癮治療領域中的建議。研究方法：本研究檢索國際醫療實證資料庫及國內中文資料庫，由兩位精神專科醫師評讀文獻，評估其實證證據等級，最終從377篇文獻中篩選出9篇符合矩陣治療模式設計架構，並提供尿液藥物篩檢結果、成癮嚴重度、留置率和停用成癮物質時間等療效指標的文獻進行分析。研究結果：第一，矩陣治療模式具有結構化課程、操作手冊及定期監測機制，可在不同的場域中使用，而其治療效果與留置率和參與程度有關，因此個案須持續投入治療活動才能有所成效；第二，個案接受治療的時間會受經濟收入及社會地位的影響；第三，與回顧的文獻相比，臺灣有高比例非自願就醫的緩起訴個案，治療者需考慮如何提升他們的治療意願。研究結論：由於矩陣治療模式有劑量－反應關係，如何在治療頻率與治療效果之間取得平衡，將會是臺灣發展本土化矩陣治療模式的一大挑戰。此外，考慮到臺灣的社會文化背景，將司法和社會福利系統與醫療保健系統整合也相當重要。

Purpose: The Matrix Model is a structured, intensive treatment protocol that has been widely used in the treatment of substance use disorders, especially for cocaine or methamphetamine use disorders. The model has also been combined with numerous psychological treatment approaches. This study has 3 primary purposes. The first is to abstract the therapeutic factors and limitations of the Matrix Model by exploring the developmental context and theoretical framework presented in the literature. The second purpose is to summarize the potential factors that affect treatment results, which we achieve by reviewing the relevant literature on the effectiveness of the Matrix Model with people of different cultural backgrounds. Our third purpose is to suggest precautions for applying the Matrix Model in Taiwan. Methods: We first searched international medical empirical databases and domestic Chinese databases to identify 377 potential articles for analysis. Two reviewers, who were psychiatrists, independently selected 9 focal studies for the literature review that conformed to the Matrix Model design and included outcome measurements such as addiction severity, urine toxicology results, retention rates, and the length of abstinence. Results: The literature review confirmed that the Matrix Model has a structured curriculum design with specific operation manuals and a routine monitoring system that can be used in different clinical settings. Therapeutic effectiveness corresponded to the retention rate and the degree of participant engagement. Clients needed to engage constantly in intensive interventions to achieve positive outcomes. According to the literature review, the amount of time a patient spent on interventions may be affected by income and social status. As compared to the patient populations in the review articles, Taiwan has a relatively high proportion of clients who were judicially referred for treatment as part of a deferred prosecution program. These clients do not necessarily have enthusiasm for participating in mandatory treatment. How to enhance their willingness to participate is an open question. Conclusions: The Matrix Model appears to have a dose-response relationship with positive outcomes. Achieving a balance between treatment frequency and therapeutic effects is the key to culturally adapting the Matrix Model in Taiwan. Additionally, it will be important to integrate the judicial and social welfare systems into the health care system in order to maximize results in mandatory treatment programs.

1. Anker, A. L.,Crowley, T. J.(1982).Use of contingency contracts in specialty clinics for cocaine abuse.NIDA Research Monograph Series,41,452-459.
2. Baer, J. S.(Ed.),Marlatt, G. A.(Ed.),McMahon, R. J.(Ed.)(1993).Addictive Behaviors Across the Life Span: Prevention, Treatment and Policy Issues.Newbury Park, CA:Sage.
3. Cameron, J.,Pierce, W. D.(1994).Reinforcement, reward, and intrinsic motivation: A meta-analysis.Review of Educational research,64(3),363-423.
4. Center for Substance Abuse Treatment. (2006). Substance abuse: clinical issues in intensive outpatient treatment (SMA 06-4182). https://www.ncbi.nlm.nih.gov/books/NBK64093/
5. Dantas, L. F.,Fleck, J. L.,Oliveira, F. L. C.,Hamacher, S.(2018).No-shows in appointment scheduling-a systematic literature review.Health Policy,122(4),412-421.
6. Davidson, L. L.,Grigorenko, E. L.,Boivin, M. J.,Rapa, E.,Stein, A.(2015).A focus on adolescence to reduce neurological, mental health and substance-use disability.Nature,527(7578),161-166.
7. Donohue, B.,Azrin, N.,Allen, D. N.,Romero, V.,Hill, H. H.,Tracy, K.,Lapota, H.,Gorney, S.,Abdel-al, R.,Caldas, D.,Herdzik, K.,Bradshaw, K.,Valdez, R.,Van Hasselt, V. B.(2009).Family behavior therapy for substance abuse and other associated problems: a review of its intervention components and applicability.Behavior Modification,33(5),495-519.
8. Dutra, L.,Stathopoulou, G.,Basden, S. L.,Leyro, T. M.,Powers, M. B.,Otto, M. W.(2008).A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders.American Journal of Psychiatry,165(2),179-187.
9. Everitt, B. J.,Robbins, T. W.(2005).Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.Nature Neuroscience,8(11),1481-1489.
10. Galloway, G. P.,Marinelli-Casey, P.,Stalcup, J.,Lord, R.,Christian, D.,Cohen, J.,Reiber. C,Vandersloot, D.(2000).Treatment-as-usual in the methamphetamine treatment project.Journal of Psychoactive Drugs,32(2),165-175.
11. Gouse, H.,Magidson, J. F.,Burnhams, W.,Remmert, J. E.,Myers, B.,Joska, J. A.,Carrico, A. W.(2016).Implementation of Cognitive-Behavioral Substance Abuse Treatment in Sub-Saharan Africa: Treatment Engagement and Abstinence at Treatment Exit.PLOS One,11(1),e0147900.
12. Harada, T.(2012).The randomized controlled trial of the prison-based Japanese Matrix program (J-MAT) for methamphetamine abusers.Japanese Journal of Alcohol Studies & Drug Dependence,47(6),298-307.
13. Huber, A.,Ling, W.,Shoptaw, S.,Gulati, V.,Brethen, P.,Rawson, R.(1997).Integrating treatments for methamphetamine abuse: a psychosocial perspective.Journal of Addictive Diseases,16(4),41-50.
14. Johnson, S. W.,North, R. A.(1992).Opioids excite dopamine neurons by hyperpolarization of local interneurons.The Journal of Neuroscience,12(2),483-488.
15. Kleber, H. D.,Weiss, R. D.,Anton, R. F.,George, T. P.,Greenfield, S. F.,Kosten, T. R.,O’Brien, C. P.,Rounsaville, B. J.,Strain, E. C.,Ziedonis, D. M.,Hennessy, G.,Connery, H. S.,McIntyre, J. S.,Charles, S. C.,Anzia, D. J.,Cook, I. A.,Finnerty, M. T.,Johnson, B. R.,Nininger, J. E.,Steering Committee on Practice Guidelines(2007).Treatment of patients with substance use disorders, second edition.The American Journal of Psychiatry,164(4 Suppl),5-123.
16. Lacy, N. L.,Paulman, A.,Reuter, M. D.,Lovejoy, B.(2004).Why we don’t come: patient perceptions on no-shows.Annals of family medicine,2(6),541-545.
17. Laruelle, M.,Abi-Dargham, A.,van Dyck, C. H.,Rosenblatt, W.,Zea-Ponce, Y.,Zoghbi, S. S.,Baldwin, R. M.,Charney, D. S.,Hoffer, P. B.,Kung, H. F.,Innis, R. B.(1995).SPECT imaging of striatal dopamine release after amphetamine challenge.The Journal of Nuclear Medicine,36(7),1182-1190.
18. Leshner, A. I.(1997).Addiction is a brain disease, and it matters.Science,278(5335),45-47.
19. Magidson, J. F.,Gouse, H.,Burnhams, W.,Wu, C. Y. Y.,Myers, B.,Joska, J. A.,Carrico, A. W.(2017).Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.Addictive Behaviors,66,132-137.
20. Martino, S.,Paris, M., Jr.,Anez, L.,Nich, C.,Canning-Ball, M.,Hunkele, K.,Carroll, K. M.(2016).The Effectiveness and Cost of Clinical Supervision for Motivational Interviewing: A Randomized Controlled Trial.Journal of Substance Abuse Treatment,68,11-23.
21. Miller, W. R.(1985).Motivation for treatment: a review with special emphasis on alcoholism.Psychological bulletin,98(1),84.
22. Miller, W. R.,Rollnick, S.(1991).Motivational interviewing : preparing people to change addictive behavior.New York, NY:Guilford Press.
23. Moeeni, M.,Razaghi, E. M.,Ponnet, K.,Torabi, F.,Shafiee, S. A.,Pashaei, T.(2016).Predictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application.BMC Psychiatry,16,265-265.
24. Moher, D.,Liberati, A.,Tetzlaff, J.,Altman, D. G.,Group, A. T. P.(2009).Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.Annals of Internal Medicine,151(4),264-269.
25. National Institute on Drug Abuse(2012).Principles of drug addiction treatment: a research-based guide.Rockville, MD:National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services.
26. Obert, J. L.,London, E. D.,Rawson, R. A.(2002).Incorporating brain research findings into standard treatment: an example using the Matrix Model.Journal of Substance Abuse Treatment,23(2),107-113.
27. Obert, J. L.,McCann, M. J.,Marinelli-Casey, P.,Weiner, A.,Minsky, S.,Brethen, P.,Rawson, R.(2000).The matrix model of outpatient stimulant abuse treatment: history and description.Journal of psychoactive drugs,32(2),157-164.
28. Pearshouse, R.(2009).Compulsory Drug Treatment in Thailand: observations on the Narcotic Addict Rehabilitation Act BE 2545 (2002).
29. Perngparn, U.,Limanonda, B.,Aramrattana, A.,Pilley, C.,Areesantichai, C.,Taneepanichskul, S.(2011).Methamphetamine dependence treatment rehabilitation in Thailand: a model assessment.Journal of the Medical Association of Thailand,94(1),110-117.
30. Poznyak, V.,Reed, G. M.,Medina-Mora, M. E.(2018).Aligning the ICD-11 classification of disorders due to substance use with global service needs.Epidemiology and Psychiatric Sciences,27(3),212-218.
31. Rawson, R. A.,Gonzales, R.,Greenwell, L.,Chalk, M.(2012).Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12-and 36-month follow-ups.Journal of Psychoactive Drugs,44(4),342-349.
32. Rawson, R. A.,Marinelli-Casey, P.,Anglin, M. D.,Dickow, A.,Frazier, Y.,Gallagher, C.,Galloway, G. P.,Herrell, J.,Huber, A.,McCann, M. J.,Obert, J.,Pennell, S.,Reiber, C.,Vandersloot, D.,Zweben, J.,the Methamphetamine Treatment Project Corporate Authors(2004).A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.Addiction,99(6),708-717.
33. Rawson, R. A.,McCann, M. J.(2005).The matrix model of intensive outpatient treatment.Behavioral Health Recovery Management,3,1-37.
34. Rawson, R. A.,Obert, J. L.,McCann, M. J.,Mann, A. J.(1986).Cocaine treatment outcome: cocaine use following inpatient, outpatient, and no treatment.NIDA Research Monograph Series,67,271-277.
35. Rawson, R. A.,Obert, J.,McCann, M. J.,Ling, W.(1992).Psychological approaches for the treatment of cocaine dependence-A neurobehavioral approach.Journal of Addictive Diseases,11(2),97-119.
36. Rawson, R. A.,Obert, J.,McCann, M. J.,Ling, W.(2005).The Matrix Model: Intensive Outpatient Alcohol & Drug Treatment: A 16-Week Individualized Program: Therapist’s Manual.Center City, MN:Hazelden.
37. Rawson, R. A.,Shoptaw, S. J.,Obert, J. L.,McCann, M. J.,Hasson, A. L.,Marinelli-Casey, P. J.,Ling, W.(1995).An intensive outpatient approach for cocaine abuse treatment.Journal of Substance Abuse Treatment,12(2),117-127.
38. Rawson, R.,Huber, A.,Brethen, P.,Obert, J.,Gulati, V.,Shoptaw, S.,Ling, W.(2000).Methamphetamine and cocaine users: differences in characteristics and treatment retention.Journal of Psychoactive Drugs,32(2),233-238.
39. Shoptaw, S.,Huber, A.,Peck, J.,Yang, X.,Liu, J.,Jeff, D.,Ling, W.(2006).Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.Drug and Alcohol Dependence,85(1),12-18.
40. Shoptaw, S.,Rawson, R. A.,McCann, M. J.,Obert, J.(1994).The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.Journal of Addictive Diseases,13(4),129-141.
41. Simpson, D. D.(1979).The relation of time spent in drug abuse treatment to posttreatment outcome.The American Journal of Psychiatry,136(11),1449-1453.
42. Sobell, M. B.,Sobell, L. C.(2000).Stepped care as a heuristic approach to the treatment of alcohol problems.Journal of Consulting and Clinical Psychology,68(4),573.
43. Substance Abuse and Mental Health Services Administration. (2014). Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Counselor’s Treatment Manual [Adobe Reader version]. https://store.samhsa.gov/sites/default/files/d7/priv/sma13-4152.pdf
44. Taymoori, P.,Pashaei, T.(2016).Relapse and Risk-taking among Iranian Methamphetamine Abusers Undergoing Matrix Treatment Model.Addiction & Health,8(1),49-60.
45. Zhang, Y., Fall, P. L., & Inomata, T. (2011). Review of management and administration in the United Nations Office on Drugs and Crime (A/66/315/Add.1/Corr.1). https://digitallibrary.un.org/record/712074
46. 李宗憲,白鎮福,束連文,吳思穎,黃韻儒,林毓恩,顧以謙,李思賢(2021)。建置毒品施用者之復原與社會復歸：介紹美國物質成癮與心理健康服務部的定義與反思台灣現況。藥物濫用防治，6(2)，1-14。
47. 李思賢(2009)。美沙冬替代療法的實施背景與現況。管制藥品簡訊，39，1-3。
48. 李思賢,Festinger, David S.,楊士隆,楊浩然,吳慧菁,廖文婷,林依蒖,鄭凱寶,Dugos, Karen L.,Seymour, Brittney L.(2015)。毒品再犯風險與醫療需求分流處置評量工具之研究。刑事政策與犯罪研究論文集，18，157-183。
49. 李思賢,徐倩,蔡孟璋(2019)。分流處遇模式的提出與推行：以高雄毒品犯緩起訴分流處遇為例。藥物濫用防治，4(2)，57-74。

1. 簡穎君,蕭涵憶,歐陽文貞,黃婉茹,李俊宏(2023)。人類職能模式及敘事治療於物質使用障礙症之戒治療效－個案報告。醫學與健康期刊，12(3)，57-63。